Advertisement

Validation of hemolytic anemia discharge diagnosis codes in the French hospital database

  • Julien Maquet
    Correspondence
    Corresponding author at: Service de Médecine Interne, hôpital Purpan, CHU de Toulouse, place du Dr Baylac, 31300 Toulouse, France.
    Affiliations
    Service de Médecine Interne, CHU de Toulouse, hôpital Purpan, place du Dr Baylac, 31059 Toulouse, France

    CIC 1436, CHU de Toulouse, hôpital Purpan, place du Dr Baylac, 31059 Toulouse, France
    Search for articles by this author
  • Hélène Derumeaux
    Affiliations
    Département d'information médicale, Hôtel Dieu, 2 rue Viguerie, CHU de Toulouse, 31059 Toulouse, France
    Search for articles by this author
  • Maryse Lapeyre-Mestre
    Affiliations
    CIC 1436, CHU de Toulouse, hôpital Purpan, place du Dr Baylac, 31059 Toulouse, France

    Service de Pharmacologie Médicale et Clinique, CHU de Toulouse, 37 allées Jules Guesde, 31000 Toulouse, France

    UMR 1027 INSERM-Université de Toulouse, Faculté de Médecine, 37 allées Jules Guesde, 31000 Toulouse, France
    Search for articles by this author
  • Laurent Sailler
    Affiliations
    Service de Médecine Interne, CHU de Toulouse, hôpital Purpan, place du Dr Baylac, 31059 Toulouse, France

    CIC 1436, CHU de Toulouse, hôpital Purpan, place du Dr Baylac, 31059 Toulouse, France

    UMR 1027 INSERM-Université de Toulouse, Faculté de Médecine, 37 allées Jules Guesde, 31000 Toulouse, France
    Search for articles by this author
  • Guillaume Moulis
    Affiliations
    Service de Médecine Interne, CHU de Toulouse, hôpital Purpan, place du Dr Baylac, 31059 Toulouse, France

    CIC 1436, CHU de Toulouse, hôpital Purpan, place du Dr Baylac, 31059 Toulouse, France

    UMR 1027 INSERM-Université de Toulouse, Faculté de Médecine, 37 allées Jules Guesde, 31000 Toulouse, France
    Search for articles by this author
Published:April 24, 2020DOI:https://doi.org/10.1016/j.ejim.2020.04.030

      Highlights

      • The positive predictive value for autoimmune hemolytic anemia was 90.0%.
      • The positive predictive value for thalassemia was 85.2%.
      • The positive predictive value for sickle-cell disease was 97.6%.
      • 91.6% of patients with an Hb-SS disease code have a major sickle-cell disease.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Dhaliwal G.
        • Cornett P.A.
        • Tierney L.M.
        Hemolytic anemia.
        Am Fam Physician. 2004; 69: 2599-2606
        • Bezin J.
        • Duong M.
        • Lassalle R.
        • Droz C.
        • Pariente A.
        • Blin P.
        • et al.
        The national healthcare system claims databases in France, Sniiram and EGB: powerful tools for pharmacoepidemiology.
        Pharmacoepidemiol Drug Saf. 2017; 26: 954-962https://doi.org/10.1002/pds.4233
        • Moulis G.
        • Lapeyre-Mestre M.
        • Palmaro A.
        • Pugnet G.
        • Montastruc J.-L.
        • Sailler L.
        French health insurance databases: what interest for medical research?.
        Rev Med Interne. 2015; 36: 411-417https://doi.org/10.1016/j.revmed.2014.11.009
        • Tuppin P.
        • de Roquefeuil L.
        • Weill A.
        • Ricordeau P.
        • Merlière Y.
        French national health insurance information system and the permanent beneficiaries sample.
        Rev Epidemiol Sante Publique. 2010; 58: 286-290https://doi.org/10.1016/j.respe.2010.04.005
        • Moulis G.
        • Palmaro A.
        • Montastruc J.-L.
        • Godeau B.
        • Lapeyre-Mestre M.
        • Sailler L.
        Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France.
        Blood. 2014; 124: 3308-3315https://doi.org/10.1182/blood-2014-05-578336
        • Moulis G.
        • Lapeyre-Mestre M.
        • Palmaro A.
        • Sailler L.
        Infections in non-splenectomized persistent or chronic primary immune thrombocytopenia adults: risk factors and vaccination effect.
        J Thromb Haemost. 2017; 15: 785-791https://doi.org/10.1111/jth.13622
        • Moulis G.
        • Lapeyre-Mestre M.
        • Mahévas M.
        • Montastruc J.-L.
        • Sailler L.
        Need for an improved vaccination rate in primary immune thrombocytopenia patients exposed to rituximab or splenectomy. A nationwide population-based study in France: vaccine exposure before rituximab and splenectomy in ITP.
        Am J Hematol. 2015; 90: 301-305https://doi.org/10.1002/ajh.23930
        • Moulis G.
        • Palmaro A.
        • Sailler L.
        • Lapeyre-Mestre M.
        Corticosteroid risk function of severe infection in primary immune thrombocytopenia adults. A nationwide nested case-control study.
        PLoS ONE. 2015; 10e0142217https://doi.org/10.1371/journal.pone.0142217
        • Clopper C.J.
        • Pearson E.S.
        The use of confidence or fiducial limits illustrated in the case of the binomial.
        Biometrika. 1934; 26: 404-413https://doi.org/10.1093/biomet/26.4.404
        • Hansen D.L.
        • Overgaard U.M.
        • Pedersen L.
        • Frederiksen H
        Positive predictive value of diagnosis coding for hemolytic anemias in the Danish National Patient Register.
        Clin Epidemiol. 2016; 8: 241-252https://doi.org/10.2147/CLEP.S93643